Even with extraordinary technological advances in drug discovery, more than 95% of diseases don’t have approved treatments. Moreover, existing efforts to close this gap are highly inefficient, necessitating the need to explore novel and diverse mechanisms of action. Molecules from medicinal plants represent an enormous untapped library of unique drug-like chemicals that can be developed into first-in-class small molecule drugs. Enveda’s advanced technological platform mitigates many of the drug discovery challenges previously associated with identifying bioactive novel molecules from plants,  paving the way for the next generation of small molecule therapeutics.

new molecules

Traditional approaches to finding hits and leads for drug discovery projects largely neglect the vast potential that exists in natural products derived from plants. At Enveda, we use cutting-edge, proprietary technologies to explore, identify, and link these novel scaffolds to complex disease phenotypes and protein targets, hundreds at a time. We then perform targeted and parallel optimization of high-value scaffolds for first-in-class clinical candidates.